Related Experiment Video
Updated: Mar 14, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.4K
Summary
Researchers should conduct fewer clinical trials, focusing only on high-quality studies. Research ethics committees could prohibit lower-quality clinical research to improve overall scientific value and applicability.
Area of Science:
- Clinical Research Ethics
- Research Quality Assessment
Background:
- Exponential growth in clinical research volume challenges data processing and absorption.
- Current research output may exceed our capacity to derive meaningful insights.
- A critical evaluation of research quantity and quality is necessary.
Purpose of the Study:
- To propose and evaluate the restriction of clinical trials to only high-quality research.
- To explore the role of research ethics committees (RECs) in prohibiting lower-quality studies.
- To analyze the social-value requirement in ethical clinical research.
Main Methods:
- Critical analysis of the proposal to limit clinical trials based on quality.
- Examination of the definition and characteristics of high-quality clinical research.
- Discussion of pragmatic versus explanatory trial designs.
Main Results:
- The proposal to conduct fewer, higher-quality clinical trials is deemed defensible.
- Applicability, particularly in real-world settings, is proposed as a key marker of research quality.
- Pragmatic trial designs are favored for their direct support of clinical decision-making.
Conclusions:
- Limiting clinical research to high-quality, applicable studies is ethically justifiable.
- Research ethics committees should consider prohibiting lower-quality research.
- Focusing on applicable evidence generation enhances the social value of clinical research.
Related Concept Videos
01:16Clinical Trials
11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.1K
01:11Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
01:28Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
01:22Case Studies
13.8K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
13.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
519
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
519
01:12Hazard Ratio
683
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
683